514 related articles for article (PubMed ID: 32711817)
1. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
2. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
[TBL] [Abstract][Full Text] [Related]
3. Psychiatry in a Dish: Stem Cells and Brain Organoids Modeling Autism Spectrum Disorders.
Ilieva M; Fex Svenningsen Å; Thorsen M; Michel TM
Biol Psychiatry; 2018 Apr; 83(7):558-568. PubMed ID: 29295738
[TBL] [Abstract][Full Text] [Related]
4. Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids.
Santos JLS; Araújo CA; Rocha CAG; Costa-Ferro ZSM; Souza BSF
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830629
[TBL] [Abstract][Full Text] [Related]
5. Modeling the autistic cell: iPSCs recapitulate developmental principles of syndromic and nonsyndromic ASD.
Ben-Reuven L; Reiner O
Dev Growth Differ; 2016 Jun; 58(5):481-91. PubMed ID: 27111774
[TBL] [Abstract][Full Text] [Related]
6. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.
Nestor MW; Phillips AW; Artimovich E; Nestor JE; Hussman JP; Blatt GJ
Autism Res; 2016 May; 9(5):513-35. PubMed ID: 26426199
[TBL] [Abstract][Full Text] [Related]
7. Modeling of Autism Using Organoid Technology.
Choi H; Song J; Park G; Kim J
Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
9. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients.
Lim CS; Yang JE; Lee YK; Lee K; Lee JA; Kaang BK
Mol Brain; 2015 Sep; 8(1):57. PubMed ID: 26419846
[TBL] [Abstract][Full Text] [Related]
10. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
[TBL] [Abstract][Full Text] [Related]
12. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
Gabriel E; Gopalakrishnan J
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells as a tool to study brain circuits in autism-related disorders.
Vitrac A; Cloëz-Tayarani I
Stem Cell Res Ther; 2018 Aug; 9(1):226. PubMed ID: 30139379
[TBL] [Abstract][Full Text] [Related]
14. Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation.
Allende ML; Cook EK; Larman BC; Nugent A; Brady JM; Golebiowski D; Sena-Esteves M; Tifft CJ; Proia RL
J Lipid Res; 2018 Mar; 59(3):550-563. PubMed ID: 29358305
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells.
Wang P; Mokhtari R; Pedrosa E; Kirschenbaum M; Bayrak C; Zheng D; Lachman HM
Mol Autism; 2017; 8():11. PubMed ID: 28321286
[TBL] [Abstract][Full Text] [Related]
16. Reaching into the toolbox: Stem cell models to study neuropsychiatric disorders.
Whiteley JT; Fernandes S; Sharma A; Mendes APD; Racha V; Benassi SK; Marchetto MC
Stem Cell Reports; 2022 Feb; 17(2):187-210. PubMed ID: 35063127
[TBL] [Abstract][Full Text] [Related]
17. The use of iPSC technology for modeling Autism Spectrum Disorders.
Russo FB; Brito A; de Freitas AM; Castanha A; de Freitas BC; Beltrão-Braga PCB
Neurobiol Dis; 2019 Oct; 130():104483. PubMed ID: 31129084
[TBL] [Abstract][Full Text] [Related]
18. The use of stem cells to study autism spectrum disorder.
Ardhanareeswaran K; Coppola G; Vaccarino F
Yale J Biol Med; 2015 Mar; 88(1):5-16. PubMed ID: 25745370
[TBL] [Abstract][Full Text] [Related]
19. Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models.
Kaindl J; Winner B
Curr Top Behav Neurosci; 2019; 42():159-183. PubMed ID: 31407242
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Induced Pluripotent Stem Cells (iPSCs) and Cerebral Organoids for Drug Screening and Development in Autism Spectrum Disorder: Opportunities and Challenges.
Villa C; Combi R; Conconi D; Lavitrano M
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33669772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
